Skip to main content
Erschienen in: Gut Pathogens 1/2014

Open Access 01.09.2014 | Genome Announcement

A draft genome of Escherichia coli sequence type 127 strain 2009-46

verfasst von: Aaron E Darling, Jessica McKinnon, Paul Worden, Jerran Santos, Ian G Charles, Piklu Roy Chowdhury, Steven P Djordjevic

Erschienen in: Gut Pathogens | Ausgabe 1/2014

Abstract

Background

Escherichia coli are a frequent cause of urinary tract infections (UTI) and are thought to have a foodborne origin. E. coli with sequence type 127 (ST127) are emerging pathogens increasingly implicated as a cause of urinary tract infections (UTI) globally. A ST127 isolate (2009-46) resistant to ampicillin and trimethoprim was recovered from the urine of a 56 year old patient with a UTI from a hospital in Sydney, Australia and was characterised here.

Results

We sequenced the genome of Escherichia coli 2009-46 using the Illumina Nextera XT and MiSeq technologies. Assembly of the sequence data reconstructed a 5.14 Mbp genome in 89 scaffolds with an N50 of 161 kbp. The genome has extensive similarity to other sequenced uropathogenic E. coli genomes, but also has several genes that are potentially related to virulence and pathogenicity that are not present in the reference E. coli strain.

Conclusion

E. coli 2009-46 is a multiple antibiotic resistant, phylogroup B2 isolate recovered from a patient with a UTI. This is the first description of a drug resistant E. coli ST127 in Australia.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1757-4749-6-32) contains supplementary material, which is available to authorized users.
Aaron E Darling, Jessica McKinnon contributed equally to this work.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

JM extracted DNA and conducted all laboratory based analysis on the isolate. PW and JS constructed Illumina libraries and sequenced them. AED and PRC conducted the assembly, analysis, and data deposition. AED, SD, JM and PRC wrote the paper. IGC and PRC provided general direction. All authors read and approved the final manuscript.

Background

Escherichia coli infections of the urinary tract are among the most frequent infections reported in the developed world with an estimated 130-175 million cases per annum worldwide[1]. E. coli that cause urinary tract infections (UTI) are classified as uropathogenic Escherichia coli (UPEC), a subgroup of extraintestinal pathogenic E. coli (ExPEC). ExPEC also cause a range of afflictions including meningitis, septicaemia, and pneumonia and are genotypically and phenotypically distinct from diarrhoegenic E. coli (DEC)[2]. ExPEC are thought to be acquired orally via the consumption of contaminated food and are considered to be zoonotic pathogens[35]. The emergence of multiple antibiotic resistance among ExPEC poses a serious health threat; antibiotics are an important treatment strategy for controlling UTI.
Multilocus sequence typing (MLST) is currently the gold standard for characterising E. coli causing UTI. No clear diagnostic markers are available for identifying E. coli causing UTI, but several sequence types (ST) including ST131, ST405, ST95, ST65, ST127, and ST10 are recognised UTI pathogens[6]. ExPEC ST127 are described as community-acquired and highly virulent zoonotic pathogens[3, 6] but to our knowledge there are no genome sequences representing antibiotic resistant isolates of this emerging pathogen. Studies of E. coli causing UTI in Australia have focussed on characterising ST131[7, 8] and serogroup O75 isolates belonging to clonal complex 14[9].
Here we describe the genome sequence of E. coli ST127 isolate 2009-46, a mid-stream urinary tract isolate from a 56 year old patient from the Sydney Adventist Hospital (SAN clinic) resistant to ampicillin and trimethoprim.

Methods

The isolate was supplied on a Sensi-agar plate from the SAN laboratories in Sydney, Australia. To confirm pure culture, a loopful of the isolate was streaked onto a Luria Bertani (LB) Agar plate and incubated at 37°C for long term storage in minus 80°C as a glycerol stock. A single colony was picked from the plate and subcultured in 10 mL LB broth at 37°C overnight. To prepare the glycerol stock culture 7 mL of the overnight was used, and genomic DNA was prepared from the remaining 3 mL. Genomic DNA for sequencing was prepared using the ISOLATE II gDNA extraction kit from Bioline.

Genome sequencing

DNA was quantified using qubit flourimetry and 0.5 ng of gDNA was used as template to construct the sequencing library, using the Illumina Nextera XT library preparation protocol following the manufacturer’s instructions. However, the "PCR Clean-Up" and "Library Normalization" steps were omitted and size selection was instead performed by running balanced and pooled samples in a 1% agarose gel and excising the 600 bp to 1200 bp region of interest. The DNA was then purified from the agarose using Promega’s Wizard SV Gel and PCR Clean-Up System. Finally, an Agilent 2100 Bioanalyzer, with a High Sensitivity DNA Kit, was used to quantitate the pooled DNA library before loading onto the MiSeq with other multiplexed samples. Two MiSeq runs were carried out, one with paired-end 250 nt reads on MiSeq V2 chemistry and another with paired-end 300 nt reads on V3 chemistry. The first library was found to have an average insert size of 368 +/- 157 nt, while the second library had inserts with an average size 497 +/- 118 nt.

Assembly and annotation

The genome was assembled using the A5-miseq pipeline, a version of the A5 pipeline[10] that has been revised to process reads up to 500 nt long. Briefly, the A5-miseq pipeline consists of five stages: (1) read quality filtering and error correction, (2) contig assembly, (3) permissive draft scaffolding, (4) misassembly detection, and (5) conservative scaffolding. The revised A5 pipeline uses a new version of idba_ud that uses read pairing information, and that has been modified to accept reads up to 500 nt long and to construct de Bruijn graphs with k-mers up to 500 nt. These modifications provide substantial improvements in assembly contiguity.
The genome was annotated with the RAST annotation system using FigFAM release 70[11]. Putative antibiotic resistance genes and other genes of interest identified by RAST annotation were manually curated using the NCBI ORF finder and iterative BLASTn and BLASTp searches.

Quality assurance

The A5 pipeline includes a quality checking step that detects putative misassemblies by identifying clusters of read pairs that map to disjoint locations in the assembled genome. This method did not detect any putative misassemblies.

Initial findings

Sequencing generated 1,702,236 read pairs for a total of 483,658,987 nt that were assembled to reconstruct the 5,139,229 bp genome of E. coli 2009-46 in 89 scaffolds, with a scaffold N50 of 161 kbp and an N90 of 30.8 kbp. The raw (unfiltered) coverage is 94x, and after read filtering the assembly has a median depth of coverage of 61x. The annotation of this assembly identified 5084 predicted CDS and 106 predicted RNA genes. 19 genes were identified as possibly missing from the assembly by the RAST system. The overall functional profile of the genome is shown in Figure1. We conducted a phylogenetic analysis of E. coli 2009-46 using the PhyloSift software[12] to identify the most closely related organism with an available reference genome. PhyloSift works by identifying homologs in the draft genome to a set of 37 genes that are universally conserved among bacteria and archaea and present in single copy. It then adds any homologs found in the draft genome to an existing multiple sequence alignment containing the 37 genes from a subset of all genomes publicly available in the NCBI and EBI databases that is chosen to span the phylogenetic diversity of these databases. The PhyloSift reference database includes only a single representative from groups of closely related organisms. To gain additional resolution in the Escherichia, we used PhyloSift to construct a multiple alignment of the 37 marker genes from all finished E. coli genomes available in the NCBI database as of September 2013. We then inferred a phylogeny from that alignment using FastTree2[13]. The resulting analysis, shown in Figure2, identified E. coli 536 as the most closely related isolate with a finished genome available, although there was some uncertainty in the 37 gene alignment as to whether E. coli 2009-46 diverged on the same lineage as E. coli 536. We used the closely related genome of E. coli 536 as a reference for further comparative analysis.
The scaffolds of E. coli 2009-46 were reordered to match the order in the finished genome of the closely related strain E. coli 536 using the Mauve Contig Mover[14]. After reordering, the genomes had 82 predicted rearrangement breakpoints. Many of these cluster in regions containing annotated transposase genes and multi-copy transporter gene families, suggesting either homology-mediated rearrangement or misassembly has occurred at these repetitive sequences. To further characterize the structure of the genome we used the CGview webserver[15] to plot matches to annotated proteins and the GC skew of the genome, with scaffolds ordered according to the E. coli 536 reference. The CGview plot is shown in Figure3. Of note, the GC skew in E. coli 2009-46 genome appears to fluctuate frequently. This pattern is in sharp contrast to the GC skew of the E. coli 536 reference, which shows a strong pattern coinciding with the chromosome’s replication arms (data not shown). This suggests that either E. coli 2009-46 has undergone substantial genome rearrangement in the recent past, that the true genome arrangement may not match the E. coli 536 reference very closely, that undetectable misassembly errors exist in the E. coli 2009-46 genome, or that some combination of these three situations exists. We note that our assembly pipeline contains a step to detect and fix misassembly errors; none were found in the genome of E. coli 2009-46.
Comparison of the gene content between E. coli 2009-46 and the finished E. coli 536 reference genome identified 164 annotated gene functions predicted to be present only in E. coli 2009-46. Included among these are several genes related to scavenging iron, a type VII secretion system, an IncF conjugation system, mediators of hyperadherence, and copper and mercury resistance genes. The full list of gene functions found only in 2009-46 and those which 2009-46 lacks relative to the reference isolate are listed in Additional files1 and2, respectively.
The b l aTEM1 gene, conferring resistance to ampicillin, was present on scaffold 78.1 (2551 nt), while the sul2-strA-strB genes conferring resistance to sulphonamides and streptomycin was located on scaffold 67.1, which was 5064 nt long. Ends of both the scaffolds had a partial copy the insertion element IS26. The isolate also houses a clinical class 1 integron and two associated resistance genes on scaffold 71.1. One of the two resistance genes is a variant of dihydrofolate reductase (dhfr) gene which provides trimethoprim resistance to isolates and the other confers resistance to aminoglocoside antibiotics (aadA). However the scaffold, 71.1, is 3,863 nt long and also has a copy of IS26 at both ends. We identified the presence of the 3’-CS of a class 1 integron on scaffold 58.1 (6679 nt long), that had an IS26 on one end and an IS1 element on the other. Presence of IS26 elements at both ends of seven scaffolds has resulted in scaffold breaks around a region of the genome, which most likely harbours a complex resistance locus (CRL), during the assembly of the genome sequence. We were therefore unable to confirm the exact genomic location of the CRL or resistance genes.

Antibiotic resistance profile

The antibiotic resistance profile of E. coli 2009-46 was experimentally determined using the disk diffusion method. This strain was found to be resistant to Ampicillin, Trimethoprim, Sulphafurazole, Tetracycline, Streptomycin, Apramycin, Kanamycin, and Azithromycin. A full list of antibiotics tested and E. coli 2009-46 susceptibility is provided in Additional file3.
To better understand the genomic basis for the observed antibiotic resistance traits, the genome was searched for specific genes known to confer antibiotic resistance. A listing of these genes and their presence or absence in E. coli 2009-46 is provided in Additional file3.

Future directions

Improved efficiency of clinical genomics pipelines will eventually enable fine-scale epidemiological monitoring of E. coli outbreaks in real time. When fully developed, this capacity will influence clinical and public health decisions related to treatment and control of pathogen outbreaks. Genomic data such as is presented here will aid in the interpretation of data from future outbreaks.

Availability of supporting data

The draft genome assembly has been submitted to NCBI and is associated with BioSample accession SAMN02725027. Genome annotations are available from the RAST web server under accession 562.3620. The Illumina sequence reads have been deposited to the Short Read Archive under accessions SRX514806 and SRX514807. CDS: Coding DNA sequences; ORF: Open Reading frame; RAST: Rapid annotation using subsystem technology; A5: Andrew and Aaron’s Awesome Assembly; gDNA: genomic DNA; nt: Nucleotides;

Acknowledgements

This work was supported by a collaboration between the NSW Department of Primary Industries and the ithree institute. Strain was donated by the Natalie Miller of the Sydney Adventist Hospital Microbiology laboratory. We thank Fiona MacIver for providing comments on a draft of this manuscript.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​4.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

JM extracted DNA and conducted all laboratory based analysis on the isolate. PW and JS constructed Illumina libraries and sequenced them. AED and PRC conducted the assembly, analysis, and data deposition. AED, SD, JM and PRC wrote the paper. IGC and PRC provided general direction. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Russo TA, Johnson JR: Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003, 5 (5): 449-456. 10.1016/S1286-4579(03)00049-2.CrossRefPubMed Russo TA, Johnson JR: Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003, 5 (5): 449-456. 10.1016/S1286-4579(03)00049-2.CrossRefPubMed
2.
Zurück zum Zitat Russo TA, Johnson JR: Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis. 2000, 181 (5): 1753-1754. 10.1086/315418.CrossRefPubMed Russo TA, Johnson JR: Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis. 2000, 181 (5): 1753-1754. 10.1086/315418.CrossRefPubMed
3.
Zurück zum Zitat Johnson JR, Sannes MR, Croy C, Johnston B, Clabots C, Kuskowski MA, Bender J, Smith KE, Winokur PL, Belongia EA: Antimicrobial drug–resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002–2004. Emerg Infect Dis. 2007, 13 (6): 838-10.3201/eid1306.061576.PubMedCentralCrossRefPubMed Johnson JR, Sannes MR, Croy C, Johnston B, Clabots C, Kuskowski MA, Bender J, Smith KE, Winokur PL, Belongia EA: Antimicrobial drug–resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002–2004. Emerg Infect Dis. 2007, 13 (6): 838-10.3201/eid1306.061576.PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Vincent C, Boerlin P, Daignault D, Dozois CM, Dutil L, Galanakis C, Reid-Smith RJ, Tellier P-P, Tellis PA, Ziebell K, Manges AR: Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis. 2010, 16 (1): 88-10.3201/eid1601.091118.PubMedCentralCrossRefPubMed Vincent C, Boerlin P, Daignault D, Dozois CM, Dutil L, Galanakis C, Reid-Smith RJ, Tellier P-P, Tellis PA, Ziebell K, Manges AR: Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis. 2010, 16 (1): 88-10.3201/eid1601.091118.PubMedCentralCrossRefPubMed
5.
Zurück zum Zitat Jakobsen L, Garneau P, Bruant G, Harel J, Olsen S, Porsbo LJ, Hammerum A, Frimodt-Møller N: Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur J Clin Microbiol Infect Dis. 2012, 31 (6): 1121-1129. 10.1007/s10096-011-1417-5.CrossRefPubMed Jakobsen L, Garneau P, Bruant G, Harel J, Olsen S, Porsbo LJ, Hammerum A, Frimodt-Møller N: Is Escherichia coli urinary tract infection a zoonosis? Proof of direct link with production animals and meat. Eur J Clin Microbiol Infect Dis. 2012, 31 (6): 1121-1129. 10.1007/s10096-011-1417-5.CrossRefPubMed
6.
Zurück zum Zitat Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, Upton M: Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother. 2012, 67 (2): 346-356. 10.1093/jac/dkr451.CrossRefPubMed Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, Upton M: Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. J Antimicrob Chemother. 2012, 67 (2): 346-356. 10.1093/jac/dkr451.CrossRefPubMed
9.
Zurück zum Zitat Platell JL, Trott DJ, Johnson JR, Heisig P, Heisig A, Clabots CR, Johnston B, Cobbold RN: Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia. Antimicrob Agents Chemother. 2012, 56 (7): 3898-3904. 10.1128/AAC.06120-11.PubMedCentralCrossRefPubMed Platell JL, Trott DJ, Johnson JR, Heisig P, Heisig A, Clabots CR, Johnston B, Cobbold RN: Prominence of an O75 clonal group (clonal complex 14) among non-ST131 fluoroquinolone-resistant Escherichia coli causing extraintestinal infections in humans and dogs in Australia. Antimicrob Agents Chemother. 2012, 56 (7): 3898-3904. 10.1128/AAC.06120-11.PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Tritt A, Eisen JA, Facciotti MT, Darling AE: An integrated pipeline for de novo assembly of microbial genomes. PLoS ONE. 2012, 7 (9): 42304-10.1371/journal.pone.0042304. doi:10.1371/journal.pone.0042304.CrossRef Tritt A, Eisen JA, Facciotti MT, Darling AE: An integrated pipeline for de novo assembly of microbial genomes. PLoS ONE. 2012, 7 (9): 42304-10.1371/journal.pone.0042304. doi:10.1371/journal.pone.0042304.CrossRef
11.
Zurück zum Zitat Aziz R, Bartels D, Best A, DeJongh M, Disz T, Edwards R, Formsma K, Gerdes S, Glass E, Kubal M, Meyer F, Olsen G, Olson R, Osterman A, Overbeek R, McNeil L, Paarmann D, Paczian T, Parrello B, Pusch G, Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O: The RAST Server: Rapid Annotations using Subsystems Technology. BMC Genomics. 2008, 9 (1): 75-10.1186/1471-2164-9-75. doi:10.1186/1471-2164-9-75.PubMedCentralCrossRefPubMed Aziz R, Bartels D, Best A, DeJongh M, Disz T, Edwards R, Formsma K, Gerdes S, Glass E, Kubal M, Meyer F, Olsen G, Olson R, Osterman A, Overbeek R, McNeil L, Paarmann D, Paczian T, Parrello B, Pusch G, Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O: The RAST Server: Rapid Annotations using Subsystems Technology. BMC Genomics. 2008, 9 (1): 75-10.1186/1471-2164-9-75. doi:10.1186/1471-2164-9-75.PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Darling AE, Jospin G, Lowe E, Matsen IV FA, Bik HM, Eisen JA: Phylosift: phylogenetic analysis of genomes and metagenomes. PeerJ. 2014, 2: 243.CrossRef Darling AE, Jospin G, Lowe E, Matsen IV FA, Bik HM, Eisen JA: Phylosift: phylogenetic analysis of genomes and metagenomes. PeerJ. 2014, 2: 243.CrossRef
13.
Zurück zum Zitat Price MN, Dehal PS, Arkin AP: Fasttree 2–approximately maximum-likelihood trees for large alignments. PloS one. 2010, 5 (3): 9490-10.1371/journal.pone.0009490.CrossRef Price MN, Dehal PS, Arkin AP: Fasttree 2–approximately maximum-likelihood trees for large alignments. PloS one. 2010, 5 (3): 9490-10.1371/journal.pone.0009490.CrossRef
14.
Zurück zum Zitat Rissman AI, Mau B, Biehl BS, Darling AE, Glasner JD, Perna NT: Reordering contigs of draft genomes using the Mauve aligner. Bioinformatics. 2009, 25 (16): 2071-2073. 10.1093/bioinformatics/btp356.PubMedCentralCrossRefPubMed Rissman AI, Mau B, Biehl BS, Darling AE, Glasner JD, Perna NT: Reordering contigs of draft genomes using the Mauve aligner. Bioinformatics. 2009, 25 (16): 2071-2073. 10.1093/bioinformatics/btp356.PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Grant JR, Stothard P: The CGView Server: a comparative genomics tool for circular genomes. Nucleic Acids Res. 2008, 36 (suppl 2): 181-184.CrossRef Grant JR, Stothard P: The CGView Server: a comparative genomics tool for circular genomes. Nucleic Acids Res. 2008, 36 (suppl 2): 181-184.CrossRef
Metadaten
Titel
A draft genome of Escherichia coli sequence type 127 strain 2009-46
verfasst von
Aaron E Darling
Jessica McKinnon
Paul Worden
Jerran Santos
Ian G Charles
Piklu Roy Chowdhury
Steven P Djordjevic
Publikationsdatum
01.09.2014
Verlag
BioMed Central
Erschienen in
Gut Pathogens / Ausgabe 1/2014
Elektronische ISSN: 1757-4749
DOI
https://doi.org/10.1186/1757-4749-6-32

Weitere Artikel der Ausgabe 1/2014

Gut Pathogens 1/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.